SPEAKERS

MERIEM KOUAL

IMGE OZUGERGIN

BAPTISTE ARNAUD

GABRIEL MOUILLARD

MANON CAPDEVILLE

PHD STUDENTS

MERIEM KOUAL

Meriem Koual is associate professor specializing in gynecological and breast cancers managment. She has led several clinical studies, both completed and ongoing. Passionate about advancing patient care, she develops innovative clinical and translational research projects aimed at improving outcomes for women cancer.

IMGE OZUGERGIN

Imge Ozugergin is a Postdoctoral Fellow at the Cell Polarity, Migration and Cancer Unit at Institut Pasteur, under the supervision of Sandrine Etienne-Mannville. She studies mitosis and cytokinesis in glioblastoma multiforme for better patient outcomes.

BAPTISTE ARNAUD

Baptiste Arnaud is a PhD candidate in immunology at the Institut Pasteur, supervised by Philippe Bousso in the Dynamics of Immune Responses laboratory, where he studies how CAR T cells operate within tumors in vivo at the single-cell level. His work combines advanced imaging, flow cytometry, and mathematical modeling to better understand immune responses in cancer. He is also actively involved in science communication through teaching, public outreach, and the creation of the educational channel “Ordres de Grandeur.”

GABRIEL MOUILLARD

Gabriel Mouillard is a medical oncology resident at CHRU Nancy (University Hospital Center of Lorraine), whose medical studies and early clinical experiences across France and the Caribbean, including onco-dermatology rotations and the first months of residency at Gustave Roussy, have shaped a multidisciplinary perspective on cancer treatment, research, and ethics, and fostered a strong interest in combining patient care with scientific investigation.

MANON CAPDEVILLE

Manon Capdeville is a third-year PhD student in Caroline Demangel’s laboratory at the Institut Pasteur. Her team has collaborated closely with Argobio Studio, leading to the recent creation of Enodia Therapeutics. Her research focuses on synthetic inhibitors of a protein translocon to develop novel therapeutic strategies against multiple myeloma.